HSIC HENRY SCHEIN INC
Wholesale-Medical, Dental & Hospital Equipment & Supplies · Nasdaq · SEC CIK 1000228 · Fiscal year ends 12/26
Financial factors as of 2026-09-26 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.2%
TTM net income YoY7.7%
TTM EPS YoY15.1%
Revenue 3-yr CAGR2.7%
Net income 3-yr CAGR-1.8%
Margins
Gross margin31.6%
Operating margin5.2%
Net margin3.1%
FCF margin4.1%
EBITDA margin7.6%
Returns
ROE12.9%
ROA3.7%
ROIC (approx.)8.5%
Asset turnover1.22x
Leverage & solvency
Liabilities / assets58.9%
Debt / equity1.07x
Current ratio1.33x
Interest coverage4.35x
Cash quality & payout
Operating cash flow / net income1.63x
Accruals ratio-2.4%
Payout ratio—
Capex / revenue0.9%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-26 | 2026Q22026-06-27 | 2026Q12026-03-28 | 2025Q4*2025-12-27 | 2025Q32025-09-27 | 2025Q22025-06-28 | 2025Q12025-03-29 | 2024Q4*2024-12-28 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $3.47B | $3.46B | $3.37B | $3.44B | $3.34B | $3.24B | $3.17B | $3.19B |
| Cost of revenue | $2.37B | $2.36B | $2.30B | $2.37B | $2.31B | $2.22B | $2.17B | $2.20B |
| Gross profit | $1.10B | $1.10B | $1.07B | $1.06B | $1.03B | $1.02B | $1.00B | $993.00M |
| SG&A expense | $819.00M | $831.00M | $809.00M | $808.00M | $760.00M | $778.00M | $738.00M | $738.00M |
| Operating income | $193.00M | $171.00M | $182.00M | $163.00M | $164.00M | $151.00M | $175.00M | $155.00M |
| Interest expense | $42.00M | $43.00M | $39.00M | $39.00M | $38.00M | $38.00M | $35.00M | $35.00M |
| Pretax income | $160.00M | $137.00M | $150.00M | $133.00M | $134.00M | $121.00M | $145.00M | $126.00M |
| Income tax | $37.00M | $34.00M | $38.00M | $32.00M | $28.00M | $31.00M | $35.00M | $31.00M |
| Net income | $119.00M | $94.00M | $107.00M | $101.00M | $101.00M | $86.00M | $110.00M | $94.00M |
| EBITDA | $279.00M | $255.00M | $263.00M | $245.00M | $244.00M | $227.00M | $248.00M | $231.00M |
| EPS (basic) | 1.07 | 0.83 | 0.93 | — | 0.84 | 0.71 | 0.89 | — |
| EPS (diluted) | 1.06 | 0.82 | 0.92 | — | 0.84 | 0.70 | 0.88 | — |
| Weighted avg. shares (diluted) | 112.54M | 114.39M | 116.06M | — | 121.04M | 122.64M | 124.85M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $184.00M | $157.00M | $138.00M | $156.00M | $136.00M | $145.00M | $127.00M | $122.00M |
| Receivables | $1.88B | $1.76B | $1.72B | $1.65B | $1.74B | $1.65B | $1.58B | $1.48B |
| Inventory | $2.05B | $2.06B | $2.01B | $2.00B | $1.91B | $1.91B | $1.84B | $1.81B |
| Current assets | $4.78B | $4.60B | $4.50B | $4.46B | $4.39B | $4.24B | $4.04B | $3.98B |
| PP&E, net | $619.00M | $618.00M | $618.00M | $621.00M | $603.00M | $587.00M | $556.00M | $531.00M |
| Goodwill | $4.27B | $4.27B | $4.28B | $4.21B | $4.15B | $4.08B | $3.96B | $3.89B |
| Intangibles | $921.00M | $965.00M | $1.01B | $1.02B | $1.05B | $1.04B | $1.03B | $1.02B |
| Total assets | $11.51B | $11.38B | $11.30B | $11.21B | $11.10B | $10.91B | $10.48B | $10.22B |
| Current liabilities | $3.60B | $3.49B | $3.30B | $3.23B | $3.15B | $3.01B | $2.92B | $2.80B |
| Short-term debt | $1.00B | $1.02B | $1.05B | $764.00M | $913.00M | $901.00M | $867.00M | $650.00M |
| Long-term debt | $2.38B | $2.30B | $2.33B | $2.31B | $2.15B | $2.09B | $1.97B | $1.83B |
| Total debt | $3.38B | $3.32B | $3.37B | $3.07B | $3.07B | $2.99B | $2.83B | $2.48B |
| Total liabilities | $6.78B | $6.66B | $6.48B | $6.42B | $6.20B | $6.01B | $5.76B | $5.38B |
| Shareholders' equity | $3.16B | $3.16B | $3.27B | $3.25B | $3.36B | $3.44B | $3.31B | $3.39B |
| Net debt | $3.20B | $3.17B | $3.23B | $2.92B | $2.93B | $2.85B | $2.71B | $2.36B |
| Shares outstanding | 110.54M | 111.92M | 114.42M | 115.77M | 118.57M | 121.90M | 122.24M | 124.16M |
| Cash flow statement | ||||||||
| Operating cash flow | $161.00M | $242.00M | -$97.00M | $381.00M | $174.00M | $120.00M | $37.00M | $204.00M |
| Capital expenditure | $30.00M | $30.00M | $25.00M | $43.00M | $33.00M | $32.00M | $31.00M | $36.00M |
| Free cash flow | $131.00M | $212.00M | -$122.00M | $338.00M | $141.00M | $88.00M | $6.00M | $168.00M |
| Investing cash flow | -$45.00M | -$65.00M | -$63.00M | -$147.00M | -$56.00M | -$98.00M | -$99.00M | -$58.00M |
| Financing cash flow | -$90.00M | -$168.00M | $120.00M | -$206.00M | -$127.00M | $56.00M | $89.00M | -$204.00M |
| Depreciation & amortization | $86.00M | $84.00M | $81.00M | $82.00M | $80.00M | $76.00M | $73.00M | $76.00M |
| Stock-based compensation | $10.00M | $13.00M | $3.00M | $10.00M | $13.00M | $11.00M | $5.00M | $9.00M |
| Share buybacks | $125.00M | $200.00M | $125.00M | $200.00M | $203.00M | $286.00M | $161.00M | $75.00M |
Free plan shows the latest 8 periods; Pro shows all 71 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.